The medication is usually taken orally, starting on the third to fifth day of the menstrual cycle, and continued for five days. The starting dose is typically 50 mg per day, but this can be adjusted based on the patient’s response. Monitoring through ultrasound and hormonal assessments may be required to track the response to the medication.
